Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injury

High Mobility Group Box–1 Mediates Hyperoxia-Induced Impairment ofPseudomonas aeruginosaClearance and Inflammatory Lung Injury in Mice

(2013) Vivek S. Patel et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Oral Fluoroquinolones and the Risk of Retinal Detachment

(2012) Farzin Forooghian   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Unknown

(2012) Maria Entezari et al.   MOLECULAR MEDICINE

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

(2011) Victor D. Rosenthal et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands

(2010) Narayanam V. Rao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia

(2010) Ronald N. Jones   CLINICAL INFECTIOUS DISEASES

Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro

(2010) Yan Ling et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Update on the treatment of Pseudomonas aeruginosa pneumonia

(2009) A. A. El Solh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

(2009) Hulda Sigridur Hreggvidsdottir et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease

(2008) Steven M. Rowe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The anti-inflammatory effects of heparin and related compounds

(2007) Edward Young   THROMBOSIS RESEARCH